Drug intelligence / Profile preview

Feedcolon + mesalamine

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Rectal (for Some Formulations Of Mesalamine)[1][2][7]
01

Overview

Feedcolon + mesalamine is a combination drug product containing two active ingredients. Mesalamine (also known as 5-aminosalicylic acid or 5-ASA) is an anti-inflammatory agent used primarily to treat and prevent flare-ups of mild to moderately active ulcerative colitis, an inflammatory bowel disease affecting the colon. It works by exerting a topical anti-inflammatory effect on the colonic epithelial cells, likely through inhibition of cyclooxygenase and lipoxygenase pathways, thereby reducing prostaglandin and leukotriene production in the colon[1][2][6][7]. The specific identity and pharmacological role of "Feedcolon" are not established in major medical databases or literature; it may be a regional brand name or proprietary formulation combined with mesalamine for gastrointestinal use. Without further information about "Feedcolon," only the properties of mesalamine can be described with certainty.

Brand names
Feedcolon + mesalamine
02

Targets

COX15-LOX (Lysyl Oxidase)

Beyond the preview

Go deeper on Feedcolon + mesalamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Feedcolon + mesalamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call